TABIOC - Advanced Therapies and Biomarkers in Clinical Oncology

Group type R+D+I Group ( Generic )
AEI areas Biomedicine (BME)
2030 Goals and Targets
  • Health and well-being
    • Goal 3 - Target 4 @ Reduce mortality from non-communicable diseases
Areas
  • Analysing the clinical evolution and identification of diagnostic and prognostic molecular biomarkers in haematological neoplasms and soft tissue sarcomas
  • Deepening our understanding of how the Wnt/ß-catenin signalling pathway is involved in the carcinogenesis of different solid tumors
  • Studying new therapy strategies to counteract resistance to antitumor drugs in haematological neoplasms, gastrointestinal stromal tumours (GIST) and soft tissue sarcomas
Research team
Principal investigators
Dr Alemany Alonso, Regina (University Professor)
Members
  • Dr Vögler, Bernhard Oliver (University Professor)
  • Dr Obrador De Hevia, Antònia
  • MARTINEZ FONT, ESTHER
  • Dr MARTÍNEZ SERRA, JORGE JOSE
  • ROS MATEU, MARIA TERESA
  • MARTIN BROTO, JAVIER